The company's clinical development plan comprises three global Phase III studies, including two focused on infants and a third for older patients.

This time, her baby did test positive for SMA type 1, a severe neurodegenerative genetic condition that typically results in ...

Biogen’s salanersen is now heading into three Phase III trials in SMA.

Hans Schambe joins BOOST Pharma – a clinical-stage biopharmaceutical company developing novel off-the-shelf cell therapies for rare paediatric skeletal diseases – from Galecto Inc., where as president ...

Jesy Nelson has hit out in a social media rant in which she slams women who objectify and scrutinise other women's bodies. The mum-of-two, who recently announced that her baby twin girls have SMA, ...

Biotechnology firm Scholar Rock is poised to make a significant strategic shift from a development-stage company to a commercial entity. The catalyst for this t ...

Columnist Ari Anderson recently enjoyed six weeks free from searching for new members of his nursing staff. Now, he's aiming ...

Detailed price information for Voyager Therapeut (VYGR-Q) from The Globe and Mail including charting and trades.